Catalyst Pharmaceuticals Inc (CPRX) – Company Profile and SWOT Analysis

Catalyst Pharmaceuticals Inc (CPRX) – Company Profile & SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company. It focuses on in-licensing, developing and commercializing prescription drugs that target rare neurological and neuromuscular diseases. Its product portfolio includes Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in children and adults, Fycompa (perampanel) tablets and oral suspension, for the treatment of partial-onset seizures and Agamree (vamorolone) oral suspension, a corticosteroid with a novel structure for the treatment of Duchenne Muscular Dystrophy (DMD). Catalyst sells its products through a field force and a wide distribution network. The company operates in the US and through its subsidiary, in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.

Scope

Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis

An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments

News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Marathon Pharmaceuticals LLC

GSK plc

Psyadon Pharmaceuticals Inc

Marinus Pharmaceuticals Inc

ReceptoPharm Inc

Jacobus Pharmaceutical Co Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Catalyst Pharmaceuticals Inc - Key Facts

Catalyst Pharmaceuticals Inc - Key Employees

Catalyst Pharmaceuticals Inc - Key Employee Biographies

Catalyst Pharmaceuticals Inc - Major Products and Services

Catalyst Pharmaceuticals Inc - History

Catalyst Pharmaceuticals Inc - Company Statement

Catalyst Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Catalyst Pharmaceuticals Inc - Business Description

Other Break-up: Firdapse

Performance

Other Break-up: Fycompa

Performance

Other Break-up: License and Other Revenue

Performance

R&D Overview

Catalyst Pharmaceuticals Inc - Corporate Strategy

Catalyst Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Catalyst Pharmaceuticals Inc - Strengths

Catalyst Pharmaceuticals Inc - Weaknesses

Catalyst Pharmaceuticals Inc - Opportunities

Catalyst Pharmaceuticals Inc - Threats

Catalyst Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025

Catalyst Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Feb 26, 2025: Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Jan 23, 2025: Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Nov 25, 2024: Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List

Nov 13, 2024: Catalyst Pharmaceuticals Recognized Among BioSpace 2025 Best Places to Work

Nov 06, 2024: Catalyst Pharmaceuticals Reports Strong Third Quarter 2024 Financial Results and Provides Corporate Update

Aug 07, 2024: Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update

May 08, 2024: Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update

May 01, 2024: Catalyst Pharmaceuticals to Participate at the BofA Securities Health Care Conference 2024

Feb 28, 2024: Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Catalyst Pharmaceuticals Inc, Key Facts

Catalyst Pharmaceuticals Inc, Key Employees

Catalyst Pharmaceuticals Inc, Key Employee Biographies

Catalyst Pharmaceuticals Inc, Major Products and Services

Catalyst Pharmaceuticals Inc, History

Catalyst Pharmaceuticals Inc, Subsidiaries

Catalyst Pharmaceuticals Inc, Key Competitors

Catalyst Pharmaceuticals Inc, Ratios based on current share price

Catalyst Pharmaceuticals Inc, Annual Ratios

Catalyst Pharmaceuticals Inc, Annual Ratios (Cont…1)

Catalyst Pharmaceuticals Inc, Annual Ratios (Cont…2)

Catalyst Pharmaceuticals Inc, Interim Ratios

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025

Catalyst Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Catalyst Pharmaceuticals Inc, Performance Chart (2020 – 2024)

Catalyst Pharmaceuticals Inc, Ratio Charts

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025

Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports